Digital healthcare company Ro offers prescriptions for hair loss, menopause, and sexual health.
Now it's becoming the first online pharmacy to offer FDA-approved allergy treatments. The segment includes up to 50 million people in the U.S. who suffer from the chronic condition.
"If you look at a condition like allergies, it's perfect for our platform," Dr. Melynda Barnes, vice president of medical affairs, told Cheddar. "We have the capability of doing everything from diagnosis to delivery of treatment."
Ro is the parent company behind digital health clinics Roman (for men) and Rory (for women) as well as a service for dealing with nicotine addiction called Zero.
Its platforms will offer allergy medicine to patients, which furthers the startup's goal of serving as a one-stop-shop for basic health needs.
"Our goal at Ro is to be a patient's first call, and for us, that means moving toward a primary care practice," Barnes said.
Though many allergy treatments are available over the counter, research shows that 80 percent of people choose the incorrect medication on their own. Using telehealth options for quick access to a certified physician, Ro hopes to take out the guesswork for patients.
"I don't think we'll ever replace in-person care," Barnes said. "In fact, at Ro, our goal is to be a complement to our in-person colleagues."
But that hasn't stopped Ro from expanding into other aspects of personal healthcare, including spreading knowledge to patients online.
The company recently launched Health Guide, a medical handbook that is 30 percent written by doctors and 100 reviewed by them. Ro is promoting the service as a competitor to WebMD.
"Right now, we know that physicians feel like they can spend more time with really sick patients if they can take care of healthier patients through an alternative health care model like telemedicine," Barnes said.
Big tech earnings take center stage as investors digest results from Alphabet, Meta, Microsoft, Amazon, and Apple, with insights from Gil Luria of D.A. Davidson
Disney content has gone dark on YouTube TV, leaving subscribers of the Google-owned live streaming platform without access to major networks like ESPN and ABC. That’s because the companies have failed to reach a new licensing deal to keep Disney channels on YouTube TV. Depending on how long it lasts, the dispute could particularly impact coverage of U.S. college football matchups over the weekend — on top of other news and entertainment disruptions that have already arrived. In the meantime, YouTube TV subscribers who want to watch Disney channels could have little choice other than turning to the company’s own platforms, which come with their own price tags.
President Donald Trump said he has decided to lower his combined tariff rates on imports of Chinese goods to 47% after talks with Chinese leader Xi Jinping on curbing fentanyl trafficking.
Universal Music Group and AI platform Udio have settled a copyright lawsuit and will collaborate on a new music creation and streaming platform. The companies announced on Wednesday that they reached a compensatory legal settlement and new licensing agreements. These agreements aim to provide more revenue opportunities for Universal's artists and songwriters. The rise of AI song generation tools like Udio has disrupted the music streaming industry, leading to accusations from record labels. This deal marks the first since Universal and others sued Udio and Suno last year. Financial terms of the settlement weren't disclosed.
